JHS Svendgaard Laboratories Limited (NSE:JHS) filed newspaper copies of its unaudited consolidated financial results for the quarter ended 30 June 2026 on 12 August 2026, as required under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The results were published in English and Hindi editions of Business Standard.
Key Highlights
- Consolidated total income from operations for Q1 FY27 stood at Rs 3,038.05 lakh, up from Rs 2,345.41 lakh in Q1 FY26, reflecting a year-on-year increase.
- Consolidated net profit after tax for Q1 FY27 was Rs 109.04 lakh, compared with Rs 105.52 lakh in the corresponding quarter of the previous year.
- Basic and diluted earnings per share on a consolidated basis were Rs 0.12 for Q1 FY27, unchanged from Rs 0.12 reported in Q1 FY26.
- The board approved these financial results at its meeting held on 11 August 2026, with the audit committee having reviewed them prior to approval.
About the Company
JHS Svendgaard Laboratories Limited (NSE:JHS) is a Himachal Pradesh-based personal care and oral hygiene contract manufacturer headquartered at Trilokpur Road, Kheri (Kala-amb), District Sirmour. The company manufactures toothbrushes, toothpaste, and allied oral care products, operating manufacturing facilities in Himachal Pradesh. It is listed on both BSE (scrip code 532771) and NSE under the ticker JHS, within the consumer goods and pharma-adjacent personal care sector.
Announcement in Detail
The company filed copies of newspaper advertisements published on 12 August 2026 in Business Standard, covering its unaudited consolidated financial results for Q1 FY27. On a consolidated basis, total income from operations reached Rs 3,038.05 lakh for the quarter ended 30 June 2026, compared with Rs 3,269.57 lakh in the immediately preceding quarter ended 31 March 2026 and Rs 2,345.41 lakh in Q1 FY26. Full-year FY26 audited consolidated income stood at Rs 10,169.47 lakh.
Consolidated net profit after tax was Rs 109.04 lakh in Q1 FY27, reversing a loss of Rs 356.86 lakh in Q4 FY26. Total comprehensive income on a consolidated basis was Rs 111.85 lakh for the quarter. Standalone figures closely mirrored consolidated results, with standalone profit after tax at Rs 109.15 lakh. Equity share capital remained at Rs 8,740.58 lakh, with each share carrying a face value of Rs 10. The results were filed with BSE and NSE under Regulation 33 of the SEBI LODR Regulations, 2015.
Impact on Investors
Investors will note that the company returned to profitability at the net level in Q1 FY27 on both a consolidated and standalone basis, after recording a consolidated net loss of Rs 356.86 lakh in Q4 FY26. The filing shows that earnings per share, both basic and diluted, stood at Rs 0.12 for the quarter, consistent with the Rs 0.12 reported in Q1 FY26, indicating that the year-on-year earnings position has held steady despite a sequential revenue dip from Q4 FY26 levels.
Shareholders will observe that there was no dividend announcement or other corporate action disclosed alongside these results. The disclosed terms indicate no change to equity share capital, which remained at Rs 8,740.58 lakh, so no dilution event is associated with this filing. The full results are available on the BSE and NSE exchange platforms for detailed review.
Sector / Market Context
India's oral care and personal hygiene segment has seen sustained volume growth, supported by rising rural consumption and government health awareness programmes. The contract manufacturing model in this segment benefits from branded companies outsourcing production to cost-efficient facilities located in tax-advantaged states such as Himachal Pradesh, which has historically attracted personal care manufacturers due to its fiscal incentive framework under past central government schemes. FMCG sector data compiled by industry bodies such as CII indicates steady demand for oral hygiene products across urban and semi-urban markets in India.